Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Robust biofilm assay for quantification and high throughput screening applications.

Rajamani S, Sandy R, Kota K, Lundh L, Gomba G, Recabo K, Duplantier A, Panchal RG.

J Microbiol Methods. 2019 Apr;159:179-185. doi: 10.1016/j.mimet.2019.02.018. Epub 2019 Feb 28.

PMID:
30826440
2.

Characterization of the plasma proteome of nonhuman primates during Ebola virus disease or melioidosis: a host response comparison.

Ward MD, Brueggemann EE, Kenny T, Reitstetter RE, Mahone CR, Trevino S, Wetzel K, Donnelly GC, Retterer C, Norgren RB Jr, Panchal RG, Warren TK, Bavari S, Cazares LH.

Clin Proteomics. 2019 Feb 7;16:7. doi: 10.1186/s12014-019-9227-3. eCollection 2019.

3.

The Biophysical Interaction of the Danger-Associated Molecular Pattern (DAMP) Calreticulin with the Pattern-Associated Molecular Pattern (PAMP) Lipopolysaccharide.

Pandya UM, Egbuta C, Abdullah Norman TM, Chiang CE, Wiersma VR, Panchal RG, Bremer E, Eggleton P, Gold LI.

Int J Mol Sci. 2019 Jan 18;20(2). pii: E408. doi: 10.3390/ijms20020408.

4.

Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action.

Selaković Ž, Tran JP, Kota KP, Lazić M, Retterer C, Besch R, Panchal RG, Soloveva V, Sean VA, Jay WB, Pavić A, Verbić T, Vasiljević B, Kuehl K, Duplantier AJ, Bavari S, Mudhasani R, Šolaja BA.

Eur J Med Chem. 2019 Jan 15;162:32-50. doi: 10.1016/j.ejmech.2018.10.061. Epub 2018 Oct 31.

PMID:
30408747
5.

Bioengineering of bacterial pathogens for noninvasive imaging and in vivo evaluation of therapeutics.

Rajamani S, Kuszpit K, Scarff JM, Lundh L, Khan M, Brown J, Stafford R, Cazares LH, Panchal RG, Bocan T.

Sci Rep. 2018 Aug 22;8(1):12618. doi: 10.1038/s41598-018-30806-x.

6.

Mitigating the Impact of Antibacterial Drug Resistance through Host-Directed Therapies: Current Progress, Outlook, and Challenges.

Chiang CY, Uzoma I, Moore RT, Gilbert M, Duplantier AJ, Panchal RG.

MBio. 2018 Jan 30;9(1). pii: e01932-17. doi: 10.1128/mBio.01932-17. Review.

7.

Bacterial genome engineering and synthetic biology: combating pathogens.

Krishnamurthy M, Moore RT, Rajamani S, Panchal RG.

BMC Microbiol. 2016 Nov 4;16(1):258. Review.

8.

Biochip for the Detection of Bacillus anthracis Lethal Factor and Therapeutic Agents against Anthrax Toxins.

Silin V, Kasianowicz JJ, Michelman-Ribeiro A, Panchal RG, Bavari S, Robertson JW.

Membranes (Basel). 2016 Jun 24;6(3). pii: E36. doi: 10.3390/membranes6030036.

9.

L1000CDS2: LINCS L1000 characteristic direction signatures search engine.

Duan Q, Reid SP, Clark NR, Wang Z, Fernandez NF, Rouillard AD, Readhead B, Tritsch SR, Hodos R, Hafner M, Niepel M, Sorger PK, Dudley JT, Bavari S, Panchal RG, Ma'ayan A.

NPJ Syst Biol Appl. 2016;2. pii: 16015. doi: 10.1038/npjsba.2016.15. Epub 2016 Aug 4.

10.

Characterization of the murine macrophage response to infection with virulent and avirulent Burkholderia species.

Chiang CY, Ulrich RL, Ulrich MP, Eaton B, Ojeda JF, Lane DJ, Kota KP, Kenny TA, Ladner JT, Dickson SP, Kuehl K, Raychaudhuri R, Sun M, Bavari S, Wolcott MJ, Covell D, Panchal RG.

BMC Microbiol. 2015 Nov 6;15:259. doi: 10.1186/s12866-015-0593-3.

11.

A reverse-phase protein microarray-based screen identifies host signaling dynamics upon Burkholderia spp. infection.

Chiang CY, Uzoma I, Lane DJ, Memišević V, Alem F, Yao K, Kota KP, Bavari S, Wallqvist A, Hakami RM, Panchal RG.

Front Microbiol. 2015 Jul 27;6:683. doi: 10.3389/fmicb.2015.00683. eCollection 2015.

12.

Evaluation of Ebola Virus Inhibitors for Drug Repurposing.

Madrid PB, Panchal RG, Warren TK, Shurtleff AC, Endsley AN, Green CE, Kolokoltsov A, Davey R, Manger ID, Gilfillan L, Bavari S, Tanga MJ.

ACS Infect Dis. 2015 Jul 10;1(7):317-26. doi: 10.1021/acsinfecdis.5b00030. Epub 2015 May 11.

PMID:
27622822
13.

Anti-Ebola Activity of Diazachrysene Small Molecules.

Selaković Ž, Soloveva V, Gharaibeh DN, Wells J, Šegan S, Panchal RG, Šolaja BA.

ACS Infect Dis. 2015 Jun 12;1(6):264-71. doi: 10.1021/acsinfecdis.5b00028. Epub 2015 May 4.

PMID:
27622742
14.

Phosphatase Inhibitors Function as Novel, Broad Spectrum Botulinum Neurotoxin Antagonists in Mouse and Human Embryonic Stem Cell-Derived Motor Neuron-Based Assays.

Kiris E, Nuss JE, Stanford SM, Wanner LM, Cazares L, Maestre MF, Du HT, Gomba GY, Burnett JC, Gussio R, Bottini N, Panchal RG, Kane CD, Tessarollo L, Bavari S.

PLoS One. 2015 Jun 10;10(6):e0129264. doi: 10.1371/journal.pone.0129264. eCollection 2015.

15.

Heat fixation inactivates viral and bacterial pathogens and is compatible with downstream MALDI mass spectrometry tissue imaging.

Cazares LH, Van Tongeren SA, Costantino J, Kenny T, Garza NL, Donnelly G, Lane D, Panchal RG, Bavari S.

BMC Microbiol. 2015 May 13;15:101. doi: 10.1186/s12866-015-0431-7.

16.

SRC family kinase inhibitors antagonize the toxicity of multiple serotypes of botulinum neurotoxin in human embryonic stem cell-derived motor neurons.

Kiris E, Burnett JC, Nuss JE, Wanner LM, Peyser BD, Du HT, Gomba GY, Kota KP, Panchal RG, Gussio R, Kane CD, Tessarollo L, Bavari S.

Neurotox Res. 2015 May;27(4):384-98. doi: 10.1007/s12640-015-9526-z. Epub 2015 Mar 18.

17.

Host response during Yersinia pestis infection of human bronchial epithelial cells involves negative regulation of autophagy and suggests a modulation of survival-related and cellular growth pathways.

Alem F, Yao K, Lane D, Calvert V, Petricoin EF, Kramer L, Hale ML, Bavari S, Panchal RG, Hakami RM.

Front Microbiol. 2015 Feb 13;6:50. doi: 10.3389/fmicb.2015.00050. eCollection 2015.

18.

A high content imaging assay for identification of Botulinum neurotoxin inhibitors.

Kota KP, Soloveva V, Wanner LM, Gomba G, Kiris E, Panchal RG, Kane CD, Bavari S.

J Vis Exp. 2014 Nov 14;(93):e51915. doi: 10.3791/51915.

19.

Rational design of small molecules as vaccine adjuvants.

Wu TY, Singh M, Miller AT, De Gregorio E, Doro F, D'Oro U, Skibinski DA, Mbow ML, Bufali S, Herman AE, Cortez A, Li Y, Nayak BP, Tritto E, Filippi CM, Otten GR, Brito LA, Monaci E, Li C, Aprea S, Valentini S, Calabrό S, Laera D, Brunelli B, Caproni E, Malyala P, Panchal RG, Warren TK, Bavari S, O'Hagan DT, Cooke MP, Valiante NM.

Sci Transl Med. 2014 Nov 19;6(263):263ra160. doi: 10.1126/scitranslmed.3009980.

20.

Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names.

Kuhn JH, Andersen KG, Bào Y, Bavari S, Becker S, Bennett RS, Bergman NH, Blinkova O, Bradfute S, Brister JR, Bukreyev A, Chandran K, Chepurnov AA, Davey RA, Dietzgen RG, Doggett NA, Dolnik O, Dye JM, Enterlein S, Fenimore PW, Formenty P, Freiberg AN, Garry RF, Garza NL, Gire SK, Gonzalez JP, Griffiths A, Happi CT, Hensley LE, Herbert AS, Hevey MC, Hoenen T, Honko AN, Ignatyev GM, Jahrling PB, Johnson JC, Johnson KM, Kindrachuk J, Klenk HD, Kobinger G, Kochel TJ, Lackemeyer MG, Lackner DF, Leroy EM, Lever MS, Mühlberger E, Netesov SV, Olinger GG, Omilabu SA, Palacios G, Panchal RG, Park DJ, Patterson JL, Paweska JT, Peters CJ, Pettitt J, Pitt L, Radoshitzky SR, Ryabchikova EI, Saphire EO, Sabeti PC, Sealfon R, Shestopalov AM, Smither SJ, Sullivan NJ, Swanepoel R, Takada A, Towner JS, van der Groen G, Volchkov VE, Volchkova VA, Wahl-Jensen V, Warren TK, Warfield KL, Weidmann M, Nichol ST.

Viruses. 2014 Sep 26;6(9):3663-82. doi: 10.3390/v6093663.

Supplemental Content

Loading ...
Support Center